Assignee
POTENZA THERAPEUTICS INC
US·7 granted patents·2 pending applications·41 citations·filing 2017–2021
Top patents by PatentIndex Score
9 records- 0194US9713641B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2017·Granted Jul 25, 2017·35 cites·20 claims
- 0283US10227413B2Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·2 cites·20 claims
- 0382US10507244B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2017·Granted Dec 17, 2019·3 cites·24 claims
- 0481US11186644B2Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2019·Granted Nov 30, 2021·1 cites·11 claims
- 0568US2022098312A1Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0661US11590224B2Anti-TIGIT antigen-binding proteins and methods of uses thereofPOTENZA THERAPEUTICS INC·Filed 2019·Granted Feb 28, 2023·0 cites·8 claims
- 0758US2021269542A1Anti-gitr antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0852US10988545B2Anti-GITR antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Apr 27, 2021·0 cites·11 claims
- 0940US11453720B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·0 cites·21 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →